New Ebola vaccine trial launches as outbreak spreads in DR Congo
Summary
A new clinical trial has started to test the Ervebo vaccine against the Bundibugyo strain of the Ebola virus in the Democratic Republic of Congo (DR Congo). This trial aims to help control the current Ebola outbreak spreading in the region.Key Facts
- The vaccine being tested is called Ervebo.
- Ervebo was originally developed for the Zaire strain of Ebola.
- The trial will see if Ervebo works against the Bundibugyo strain.
- The Ebola outbreak is currently spreading in DR Congo.
- The World Health Organization (WHO) is involved in the vaccine study.
- The trial was announced on August 11, 2026.
- Ebola is a serious and often deadly virus causing outbreaks in parts of Africa.
- This effort is part of a global response to control Ebola outbreaks.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
